Enterococcus faecium (2018 Data)
Antibiotic |
% Susceptible |
Antibiotic |
% Susceptible |
|
Ampicillin | 45 |
Imipenem | +/- |
|
Azithromycin | - |
Levofloxacin | 29 |
|
Aztreonam | - |
Meropenem | - |
|
Cefazolin | - |
Moxifloxacin | +/-
|
|
Cefepime | - |
Nitrofurantoin | 53&
|
|
Ceftazidime | - |
Oxacillin/Naf | - |
|
Ceftriaxone | - |
Penicillin | 43 |
|
Cefuroxime | - |
Piperacillin | +/-
|
|
Ciprofloxacin | 25 |
Piperacillin/tazo | +/- |
|
Clarithromycin | - |
Ticarcillin/Clav | -* |
|
Clindamycin | - |
Tobramycin | - |
|
Doxycycline | 41 |
TMP/SMX | - |
|
Erythromycin | - |
Unasyn/Aug | ||
Gentamicin | 96S |
Vancomycin | 63 |
|
Number of isolates tested: 51
Comments:
For historical susceptibility data click here
Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections